ES509653A0 - Un procedimiento para la preparacion de fosfonamidas sustituidas. - Google Patents

Un procedimiento para la preparacion de fosfonamidas sustituidas.

Info

Publication number
ES509653A0
ES509653A0 ES509653A ES509653A ES509653A0 ES 509653 A0 ES509653 A0 ES 509653A0 ES 509653 A ES509653 A ES 509653A ES 509653 A ES509653 A ES 509653A ES 509653 A0 ES509653 A0 ES 509653A0
Authority
ES
Spain
Prior art keywords
phosphonamides
substituted
procedure
preparation
substituted phosphonamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES509653A
Other languages
English (en)
Other versions
ES8307263A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8307263A1 publication Critical patent/ES8307263A1/es
Publication of ES509653A0 publication Critical patent/ES509653A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES509653A 1981-02-17 1982-02-16 Un procedimiento para la preparacion de fosfonamidas sustituidas. Granted ES509653A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23533681A 1981-02-17 1981-02-17
US06/318,221 US4379146A (en) 1981-02-17 1981-11-05 Substituted phosphonamides as antihypertensives

Publications (2)

Publication Number Publication Date
ES8307263A1 ES8307263A1 (es) 1983-07-01
ES509653A0 true ES509653A0 (es) 1983-07-01

Family

ID=26928818

Family Applications (1)

Application Number Title Priority Date Filing Date
ES509653A Granted ES509653A0 (es) 1981-02-17 1982-02-16 Un procedimiento para la preparacion de fosfonamidas sustituidas.

Country Status (6)

Country Link
US (1) US4379146A (es)
EP (1) EP0058427A3 (es)
DK (1) DK65882A (es)
ES (1) ES509653A0 (es)
GR (1) GR74785B (es)
PT (1) PT74444B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1276392C (en) * 1981-08-03 1990-11-13 Donald S. Karanewsky Phosphonamidate compounds
US4432972A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds
US4432971A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds
US4555506A (en) * 1981-12-24 1985-11-26 E. R. Squibb & Sons, Inc. Phosphorus containing compounds and use as hypotensives
US4716155A (en) * 1981-12-24 1987-12-29 E. R. Squibb & Sons, Inc. Phosphorus containing compounds and hypotensive use thereof
DE3381378D1 (de) * 1982-01-23 1990-05-03 Ajinomoto Kk Derivate von aminosaeuren und antihypertensive arzneimittel diese enthaltend.
US4560680A (en) * 1982-03-15 1985-12-24 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
US4452791A (en) * 1982-03-15 1984-06-05 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
US4448772A (en) * 1982-04-22 1984-05-15 E. R. Squibb & Sons, Inc. Phosphinylmethylaminocarbonyl imino acid compounds useful for treating hypertension
US4560681A (en) * 1982-04-22 1985-12-24 E. R. Squibb & Sons, Inc. Phosphinylmethylaminocarbonyl imino acid compounds useful for treating hypertension
US4616005A (en) * 1982-06-23 1986-10-07 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
US4452790A (en) * 1982-06-23 1984-06-05 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
US4703043A (en) * 1982-06-23 1987-10-27 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive
US4460579A (en) * 1983-02-28 1984-07-17 E. R. Squibb & Sons, Inc. Thiazine and thiazepine containing compounds
US4555579A (en) * 1983-03-24 1985-11-26 E. R. Squibb & Sons, Inc. Dioxolenylmethyl ester prodrugs of phosphinic acid ace inhibitors
US4533661A (en) * 1983-03-28 1985-08-06 E. R. Squibb & Sons, Inc. Certain 3-phosphinyl-amino-2-oxo-1H-azepine-1-acetic acid derivatives having anti-hypertensive activity
US4567167A (en) * 1983-03-28 1986-01-28 E. R. Squibb & Sons, Inc. Certain 3-phosphinyl-2-oxo-piperidine-1-acetic acid derivatives having anti-hypertensive activity
US4598071A (en) * 1983-03-28 1986-07-01 E. R. Squibb & Sons, Inc. Certain 3-phosphinyl-amino-2-oxo-1H-azocine or azonine-1-acetic acid derivatives having anti-hypertensive properties
US4558034A (en) * 1984-01-31 1985-12-10 The Board Of Trustees Of The University Of Kentucky Inhibitors of bacterial collagenase
ATE50999T1 (de) * 1985-06-11 1990-03-15 Ciba Geigy Ag Mikrobizide mittel.
US5189030A (en) * 1985-06-11 1993-02-23 Ciba-Geigy Corporation 1-amino-2-phenylethanephosphonic acids as microbiocides
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
US4931430A (en) * 1987-12-14 1990-06-05 E. R. Squibb & Sons, Inc. Method for preventing or treating anxiety employing an ACE inhibitor
EP0376040A3 (en) * 1988-12-27 1990-09-12 American Cyanamid Company N-phosphinyl di-and tripeptides as renin inhibitors
US5189023A (en) * 1990-09-04 1993-02-23 American Cyanamid Company Renin inhibitors
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
US5098889A (en) * 1990-09-17 1992-03-24 E. R. Squibb & Sons, Inc. Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
FR2676059B1 (fr) * 1991-05-02 1993-07-23 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
JPH05105698A (ja) * 1991-06-13 1993-04-27 Takeda Chem Ind Ltd ホスホン酸誘導体、その製造法および用途
IT1274673B (it) * 1994-04-14 1997-07-24 Zambon Spa Derivati dell'acido fosfonico utili nel trattamento delle malattie car.iovascolari
IT1270260B (it) * 1994-06-21 1997-04-29 Zambon Spa Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
IT1273455B (it) * 1995-01-27 1997-07-08 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
IT1276710B1 (it) * 1995-06-14 1997-11-03 Zambon Spa Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi
JP2002525323A (ja) * 1998-09-25 2002-08-13 スノル・モレキュラー・コーポレーション 医薬活性化合物及びその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151172A (en) * 1977-08-11 1979-04-24 E. R. Squibb & Sons, Inc. Phosphonoacyl prolines and related compounds
US4316896A (en) * 1978-09-07 1982-02-23 Merck & Co., Inc. Aminoacid derivatives as antihypertensives
US4168267A (en) * 1978-10-23 1979-09-18 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl prolines

Also Published As

Publication number Publication date
ES8307263A1 (es) 1983-07-01
US4379146A (en) 1983-04-05
EP0058427A2 (en) 1982-08-25
PT74444B (en) 1985-01-04
PT74444A (en) 1982-03-01
EP0058427A3 (en) 1983-10-05
GR74785B (es) 1984-07-12
DK65882A (da) 1982-08-18

Similar Documents

Publication Publication Date Title
ES509653A0 (es) Un procedimiento para la preparacion de fosfonamidas sustituidas.
ES513366A0 (es) Un procedimiento para la preparacion de nuevas n-aril-piperazin alcanamidas.
ES515889A0 (es) Un procedimiento para la preparacion de compuestos.
ES512882A0 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
ES517542A0 (es) Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b.
ES510696A0 (es) Un procedimiento para la preparacion de nuevos tiojenos o furanos.
ES511123A0 (es) Un procedimiento para la preparacion de un dihidroxi-compuesto.
ES512561A0 (es) Un procedimiento para la preparacion de un eter 2-hidroxi-3-alcoxi-propilglicerilico.
ES511124A0 (es) Un procedimiento para la preparacion de un dihidroxi-compuesto.
ES517222A0 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
ES514264A0 (es) Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas.
ES512880A0 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES509437A0 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
ES511663A0 (es) Un procedimiento para la preparacion de un heteropoliacido.
ES513880A0 (es) Un procedimiento para la preparacion de derivados de triazolurea.
ES514311A0 (es) Un procedimiento para la preparacion de benzofurasulfamatos.
ES514992A0 (es) Un procedimiento para la preparacion de un derivado carbostirilo.
ES509312A0 (es) Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona.
ES511665A0 (es) Un procedimiento para la preparacion de fenilaminoimidazolidinas.
ES515655A0 (es) Un procedimiento para la preparacion de derivados de benzotiazolina.
ES509432A0 (es) Un procedimiento para la preparacion de arilaminas.
ES510611A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina.
ES513967A0 (es) Un procedimiento para la preparacion de derivados de etanola-mina.
ES508809A0 (es) Un procediemento para la preparacion de un derivado de piridoindol.
ES521152A0 (es) Un procedimiento para la preparacion de glutation.